91ÑÇÉ«

AI in Healthcare: Application in Medical Imaging

COVID-19 Showed the Benefits of 3D-Printing in Healthcare. Can IP get out of the way?

Federal Court rules in favour of Janssen for its combination therapy patent

The Competition Bureau And Health Canada Issue Joint Notice On Continued Collaboration In Pharmaceutical Sector

Evolving Perspectives: USPTO Call for Comments on Patent Eligibility Comes to a Close (Part 1)

Insulin Biohackers: Shaking Up a Billion-Dollar Industry

A Win for Patent Law and a Loss for Prostate Cancer

What Makes It My Molecule: A Look at Professor Ronald Pearlman’s Genome Editing Work

This past November, Professor Ronald E. Pearlman from 91ÑÇɫ’s Department of Biology gave a talk [1] at Osgoode Hall Law School to discuss the potential of the innovative CRISPR genome editing system. Central to the talk was the evolving nature of genome editing technology and the ethical concerns that come with its growing breadth of […]

Trade Secrets, Transparency, and Temporality

Access to information is generally important in a free and democratic society. It’s particularly important in the context of regulating drugs, medical devices, and other products. In Merck Frosst Canada Ltd. v. Canada (Health), the Supreme Court of Canada affirmed Health Canada’s decision to disclose certain information about Merck’s asthma medication Singulair®. The Court rejected […]